THE SCOPE OF METAL COMPLEXES IN DRUG DESIGN - A REVIEW

INDIAN DRUGS ◽  
2012 ◽  
Vol 49 (11) ◽  
pp. 5-12
Author(s):  
S. R. Pattan ◽  
◽  
S. B Pawar ◽  
S. S. Vetal ◽  
U. D. Gharate ◽  
...  

A significantly rising interest in the design of metal compounds as drugs and diagnostic agents is currently observed in the area of scientific inquiry, appropriately termed medicinal inorganic chemistry. Investigations in this area focus mostly on the speciation of metal species in biological media based on possible interactions of these metal ions with diverse biomolecules, in an effort to contribute to future development of new therapeutics or diagnostic agents. Metallopharmaceuticals used as anticancer agents, metal-mediated antibiotics, antibacterials, antivirals, antiparasitics, antiarthritics, antidiabetics and radio-sensitizing agents appear in therapeutic medicinal inorganic chemistry. The medicinal uses and applications of metals and metal complexes are of increasing clinical and commercial importance.

2006 ◽  
Vol 35 (6) ◽  
pp. 545 ◽  
Author(s):  
Katherine H. Thompson ◽  
Cheri A. Barta ◽  
Chris Orvig

ChemInform ◽  
2006 ◽  
Vol 37 (37) ◽  
Author(s):  
Katherine H. Thompson ◽  
Cheri A. Barta ◽  
Chris Orvig

2018 ◽  
Vol 47 (35) ◽  
pp. 12373-12384 ◽  
Author(s):  
Claudia S. Gutsche ◽  
Susanna Gräfe ◽  
Burkhard Gitter ◽  
Keith J. Flanagan ◽  
Mathias O. Senge ◽  
...  

A post-functionalization route to tris(dipyrrinato) metal complexes is presented giving access to a range of new complexes relevant in the context of medicinal inorganic chemistry.


2020 ◽  
Vol 26 (41) ◽  
pp. 7452-7475 ◽  
Author(s):  
Marta A. Andrade ◽  
Luísa M.D.R.S. Martins

: The development of safe and effective chemotherapeutic agents is one of the uppermost priorities and challenges of medicinal chemistry and new transition metal complexes are being continuously designed and tested as anticancer agents. Scorpionate ligands have played a great role in coordination chemistry, since their discovery by Trofimenko in the late 1960s, with significant contributions in the fields of catalysis and bioinorganic chemistry. Scorpionate metal complexes have also shown interesting anticancer properties, and herein, the most recent (last decade) and relevant scorpionate complexes reported for application in medicinal chemistry as chemotherapeutic agents are reviewed. The current progress on the anticancer properties of transition metal complexes bearing homo- or hetero- scorpionate ligands, derived from bis- or tris-(pyrazol-1-yl)-borate or -methane moieties is highlighted.


Author(s):  
R. Morris Bullock ◽  
Geoffrey M. Chambers

This perspective examines frustrated Lewis pairs (FLPs) in the context of heterolytic cleavage of H 2 by transition metal complexes, with an emphasis on molecular complexes bearing an intramolecular Lewis base. FLPs have traditionally been associated with main group compounds, yet many reactions of transition metal complexes support a broader classification of FLPs that includes certain types of transition metal complexes with reactivity resembling main group-based FLPs. This article surveys transition metal complexes that heterolytically cleave H 2 , which vary in the degree that the Lewis pairs within these systems interact. Many of the examples include complexes bearing a pendant amine functioning as the base with the metal functioning as the hydride acceptor. Consideration of transition metal compounds in the context of FLPs can inspire new innovations and improvements in transition metal catalysis. This article is part of the themed issue ‘Frustrated Lewis pair chemistry’.


2008 ◽  
Vol 15 (25) ◽  
pp. 2574-2591 ◽  
Author(s):  
Christian Hartinger ◽  
Alexey Nazarov ◽  
Shaheen Ashraf ◽  
Paul Dyson ◽  
Bernhard Keppler

Sign in / Sign up

Export Citation Format

Share Document